Abstract
Islet transplantation can achieve insulin independence in individuals with type 1 diabetes. However, islets derived from multiple donors are often required, and functional beta cells are lost early after transplantation. There is thus a need for strategies to improve graft survival and function. Our lab has recently characterized Lyn as a critical regulator of beta-cell proliferation and survival. We herein sought to test the hypothesis that pharmacological activation of Lyn improves the outcome of islet transplantation in mice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.